|
WO2020262414A1
|
|
Method for promoting growth of bacteria of genus bifidobacterium
|
|
WO2020218432A1
|
|
Immune checkpoint inhibitor combination therapy using quinoline carboxamide derivative
|
|
WO2020203782A1
|
|
Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin
|
|
WO2020196374A1
|
|
Method for promoting bacterial cell wall degradation
|
|
JP2020158500A
|
|
Method for producing 1,3,4-oxa(thia)diazole-2-amine derivative
|
|
JP2020158498A
|
|
Method for producing quinolinecarboxylic acid derivative
|
|
JP2020158499A
|
|
Method for producing isatin derivative
|
|
WO2020196327A1
|
|
Production method of quinolinecarboxamide derivative or production intermediate thereof
|
|
TW202100745A
|
|
Selection medium for bacteria belonging to genus pseudomonas and use thereof
|
|
WO2020175274A1
|
|
Food/beverage product, off-flavor masking agent for food/beverage product, and off-flavor masking method for food/beverage product
|
|
JP2020132633A
|
|
Cosmetic composition and method for suppressing crystallization of easily crystallizable water-soluble active ingredient in cosmetic composition
|
|
TW202045015A
|
|
Method for producing culture of lactic acid bacterium and/or bacterium belonging to genus Bifidobacterium
|
|
WO2020121908A1
|
|
Method for measuring stool consistency and method for evaluating stool state using same
|
|
WO2020100706A1
|
|
METHOD FOR PRODUCING SECRETED β-GALACTOSIDASE
|
|
JP2020054342A
|
|
Method for producing defatted powdered milk
|
|
WO2020059705A1
|
|
Cancer combination therapy using quinoline carboxamide derivative
|
|
JP2020162489A
|
|
Milk food and drink, and method for reducing bitter taste of the same
|
|
JP2020162478A
|
|
Low-fat fermentation food product and method for producing the same
|
|
JP2020162477A
|
|
Method for producing lactic acid bacteria-fermented food
|
|
JP2020162847A
|
|
Multistage type straw, straw package, and packaged beverage
|
